122 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
Net change in cash, cash equivalents and restricted cash
Add: Net change in cash, classified within current assets held for sale
Cash, cash
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
Statement of Operations and are classified based on the Company’s classification policy for each category of operating expense.
ADDITIONAL FINANCIAL
8-K
EX-99.1
qjzma
5 Oct 23
A Statement on Emergent’s Camden Manufacturing Facility Regulatory Status
7:42am
8-K
EX-10.1
kikzwyzhyc6yyu7us
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
8-K
EX-99.1
h88om9ya7t38dmqqjl3s
9 May 23
Emergent Biosolutions Reports Financial Results for First Quarter 2023
4:05pm
CORRESP
71qi7igecr2iw8i4z
30 Sep 21
Correspondence with SEC
12:00am